Calian Group (TSE:CGY – Get Free Report) had its price objective increased by equities research analysts at Acumen Capital from C$70.00 to C$85.00 in a note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Acumen Capital’s price objective would suggest a potential upside of 20.02% from the stock’s current price.
CGY has been the topic of several other research reports. Canadian Imperial Bank of Commerce boosted their target price on shares of Calian Group from C$62.00 to C$65.00 in a research note on Wednesday, January 14th. Canaccord Genuity Group boosted their price target on shares of Calian Group from C$63.00 to C$80.00 in a research report on Friday. Ventum Financial upped their price objective on shares of Calian Group from C$62.00 to C$72.00 and gave the stock a “buy” rating in a research note on Tuesday, January 27th. Royal Bank Of Canada raised their price objective on shares of Calian Group from C$58.00 to C$60.00 and gave the stock an “outperform” rating in a report on Friday. Finally, CIBC World Markets lifted their target price on shares of Calian Group from C$65.00 to C$76.00 in a research note on Friday. Six analysts have rated the stock with a Buy rating, According to MarketBeat.com, Calian Group presently has an average rating of “Buy” and a consensus target price of C$73.43.
Check Out Our Latest Analysis on CGY
Calian Group Price Performance
Calian Group (TSE:CGY – Get Free Report) last released its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 earnings per share for the quarter. The company had revenue of C$208.00 million for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. As a group, research analysts predict that Calian Group will post 4.9475219 EPS for the current year.
About Calian Group
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Articles
- Five stocks we like better than Calian Group
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
